(VIII): The Eight Study and Immunologic Response Sub-study

Status unconfirmed

Conditions studied: Vaccine Reaction

In brief

The study's objective is to test the hypothesis that immune system activation and subsequent systemic inflammation can be detected through continuously tracking multiple bio signals including physiologic variables (ECG, skin temperature and their derivatives) and behavioral variables (activity and sleep from accelerometers) collected during routine activities of daily living using wearable biosensors. In the sub-study, the objective is to explore the association between these objectively measured physiologic changes and vaccine-induced humoral and T-cell responses.

Key facts

Study ID

NCT05237024

Run by

physIQ, Inc.

People needed

130

Starts

2021-04-15

Expected to finish

2022-12-15

Last updated by the study team

2022-02-11

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Is 18 years of age or older.
• Is able to speak and read English.
• Plan to receive either the Moderna or Pfizer vaccine (mRNA vaccine).
• No known prior COVID-19 infection.

You may not qualify if…

• Known allergy to the adhesive used on the VitalPatch.

Where it is running

• physIQ — Chicago, Illinois, United States (enrolling)
• Cell Carta — Montreal, Quebec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.